Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
aaPRP for Cytokine Storms in Severe COVID-19
NCT04715360Phase 2Unknown
- Sponsor
- Hayandra Peduli Foundation
- Start
- Dec 2020
- Primary completion
- Nov 2021
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Hayandra Peduli Foundation. Primary endpoints: Pro-inflammatory cytokines plasma level at 6 days, Anti-inflammatory cytokines plasma level at 6 days and 2 more. Status: unknown.
02
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04715360.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04715360.